Reaction equation
[Cl:1][C:2]1[N:3]=[C:4]([Cl:12])[C:5]2[N:10]([CH3:11])[N:9]=[CH:8][C:6]=2[N:7]=1.[CH3:13]N1C2C(=O)NC(=O)NC=2C(C)=N1>>[Cl:1][C:2]1[N:3]=[C:4]([Cl:12])[C:5]2[N:10]([CH3:11])[N:9]=[C:8]([CH3:13])[C:6]=2[N:7]=1Participants
3
Procedure
This compound was prepared in an analogous fashion to 5,7-dichloro-1-methyl-1H-pyrazolo[4,3-d]pyrimidine, using 1,3-dimethyl-1H-pyrazolo[4,3-d]-pyrimidine-5,7(4H,6H)-dione as the starting material. 1H NMR (CDCl3, 400 MHz) δ ppm 4.32 (s, 3H), 2.60 (s, 3H); LC-MS m/z (method B2)=217.2/219.2 [M+H]+, RT=1.688 min.
Sources & evidence
- ORD record
- ord-b0ae29bac99d4c59bc29cb7ddb2c8e4a
- Source dataset
- uspto-grants-2014_09
- Patent number
- US08828990B2
Linked notes
Loading…